Source
Use of long-acting broadly neutralizing antibodies may delay HIV rebound following discontinuation of antiretroviral therapy SECONDARY_TEXT
Retrieval by Galedra
FETCHED at 2026-09-29T01:29:09Z · https://www.2minutemedicine.com/use-of-long-acting-broadly-neutralizing-antibodies-may-delay-human-immunodeficiency-virus-hiv-rebound-following-discontinuation-of-antiretroviral-therapy/ · seq 18962
| Excerpt | Finding |
|---|---|
| Early viral rebound before week 20 occurred in 8 participants in the bNAb group versus 30 in the placebo group ... Median time to ART restart was 45.4 weeks ... | not found — this server looked at the page and did not find the passage |
Claims from this source
No claims have been extracted from this source yet.
Locations
| Locator | Excerpt |
|---|---|
QUOTE {} | Early viral rebound before week 20 occurred in 8 participants in the bNAb group versus 30 in the placebo group ... Median time to ART restart was 45.4 weeks in the bNAb group compared with 4.6 weeks in the control group. |